Vasodilator Agents

• 

  Subject Areas on Research

  • 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 
  • A comparative evaluation of the effects of multiple vasodilators on human internal mammary artery. 
  • A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with after medical therapy. Outcomes of a randomized clinical trial. Veterans Affairs Study of Angioplasty Compared to Medical Therapy Investigators. 
  • A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. 
  • A report on my headaches. 
  • Absence of bilateral vision loss from amiodarone: a randomized trial. 
  • Absence of detectable pharmacological effects after oral administration of isoxsuprine. 
  • Acute decompensated heart failure: update on new and emerging evidence and directions for future research. 
  • Acute dysphonia secondary to vocal fold hemorrhage after vardenafil use. 
  • Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. 
  • Adenosine for myocardial protection in acute myocardial infarction. 
  • Adenosine for temporary flow arrest during intracranial aneurysm surgery: a single-center retrospective review. 
  • Adenosine-induced flow arrest to facilitate intracranial aneurysm clip ligation: dose-response data and safety profile. 
  • Adenosine-induced modulation of excitatory amino acid transport across isolated brain arterioles. 
  • Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage. 
  • Advancing care for acute heart failure--no time to relax. 
  • Afterload reduction in chronic aortic regurgitation: it sure seems like a good idea. 
  • Age-related vasodilatory response to acetazolamide challenge in healthy adults: a dynamic contrast-enhanced MR study. 
  • Angiotensin protects cortical neurons from hypoxic-induced apoptosis via the angiotensin type 2 receptor. 
  • Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease. 
  • Anticoagulant responses to thrombin are enhanced during regression of atherosclerosis in monkeys. 
  • Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. 
  • Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry. 
  • Assessment of whole-brain vasodilatory capacity with acetazolamide challenge at 1.5 T using dynamic contrast imaging with frequency-shifted burst. 
  • Atrial natriuretic peptide increases adrenomedullin in the circulation of healthy humans. 
  • Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature. 
  • Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients? 
  • Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes. 
  • Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition. 
  • CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction. 
  • Calcitonin gene-related peptide and reperfusion injury. 
  • Canonical Wnt signaling induces vascular endothelial dysfunction via p66Shc-regulated reactive oxygen species. 
  • Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men. 
  • Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial. 
  • Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction. 
  • Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis. 
  • Chronic obstructive pulmonary disease: emerging medical therapies. 
  • Chronic thromboembolic pulmonary hypertension. 
  • Clarifying the Relative Impacts of Vascular and Nerve Injury That Culminate in Erectile Dysfunction in a Pilot Study Using a Rat Model of Prostate Irradiation and a Thrombopoietin Mimetic. 
  • Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. 
  • Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease. 
  • Comparative effects of L-NNA and alkyl esters of L-NNA on pulmonary vasodilator responses to ACh, BK, and SP. 
  • Comparison of relaxation responses to multiple vasodilators in TxA(2)-analog and endothelin-1-precontracted pulmonary arteries. 
  • Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging. 
  • Congestive heart failure. 
  • Congestive heart failure: Dx and Rx in the elderly. 
  • Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure. 
  • Conversation in cardiology: Is there a need for clinical trials for the nonhyperemic pressure ratios? 
  • Converting i.v. nitroglycerin therapy to nitroglycerin ointment therapy: a comparison of two methods. 
  • Coronary Microvascular Dysfunction as a Mechanism of Angina in Severe AS: Prospective Adenosine-Stress CMR Study. 
  • Correlation of intrinsic optical signal, cerebral blood flow, and evoked potentials during activation of rat somatosensory cortex. 
  • Current and novel pharmacologic approaches in advanced heart failure. 
  • Current and novel pharmacologic approaches in advanced heart failure. 
  • Diagnostic accuracy of SPECT and PET myocardial perfusion imaging in patients with left bundle branch block or ventricular-paced rhythm. 
  • Differences in health care use and outcomes by the timing of in-hospital worsening heart failure. 
  • Dipyridamole myocardial SPECT with low heart rate response indicates cardiac autonomic dysfunction in patients with diabetes. 
  • Disposition of vessel dilator and long-acting natriuretic peptide in healthy humans after a one-hour infusion. 
  • Diuretic resistance predicts mortality in patients with advanced heart failure. 
  • Does improved oxygenation really imply increased benefit? 
  • Dynamic CT perfusion imaging in subarachnoid hemorrhage-related vasospasm. 
  • Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM). 
  • Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. 
  • Echo/Doppler and hemodynamic correlates of vasodilator responsiveness in primary pulmonary hypertension. 
  • Echocardiography for the assessment of myocardial viability. 
  • Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial. 
  • Effect of anger provocation on endothelium-dependent and -independent vasodilation. 
  • Effect of calcitonin gene related peptide vs sodium nitroprusside to increase temperature in spontaneous canine tumours during local hyperthermia. 
  • Effect of cardiac cycle on ultrasound assessment of endothelial function. 
  • Effects of Serelaxin in Patients with Acute Heart Failure. 
  • Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. 
  • Effects of fenoldopam on renal blood flow and systemic hemodynamics during isoflurane anesthesia. 
  • Effects of nociceptin (13-17) in pain modulation at supraspinal level in mice. 
  • Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. 
  • Effects of treatment with pentoxifylline on the cardiovascular manifestations of group B streptococcal sepsis in the piglet. 
  • Efficacy and safety of nesiritide in patients with acute decompensated heart failure. 
  • Efficacy of ethyl nitrite in reversing surgical vasospasm. 
  • Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. 
  • Elevated Uric Acid Prevalence and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from RELAX. 
  • Endothelin-1 blockade corrects mesenteric hypoperfusion in a porcine low cardiac output model. 
  • Endovascular treatment of cerebral vasospasm. 
  • Evaluation of ischemic heart disease. 
  • Evolution of the clinical management of hypertension. Emerging role of "specific" vasodilators as initial therapy. 
  • Ex utero intrapartum treatment procedure in a patient with arthrogryposis multiplex congenita, using continuous spinal anesthesia and intravenous nitroglycerin for uterine relaxation. 
  • Extrapulmonary effects of inhaled nitric oxide: role of reversible S-nitrosylation of erythrocytic hemoglobin. 
  • Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. 
  • Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. 
  • Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. 
  • Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. 
  • Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. 
  • Functional transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 channels along different segments of the renal vasculature. 
  • GLOBAL REACH 2018: intra-arterial vitamin C improves endothelial-dependent vasodilatory function in humans at high altitude. 
  • Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. 
  • Global Coronary Flow Reserve Measured During Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events. 
  • Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection. 
  • Hemodynamic effects of vasorelaxant compounds in mice lacking one, two or all three angiotensin II receptors. 
  • Hypertension with acute coronary syndrome and heart failure. 
  • INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure. 
  • Impaired coronary vasodilation by magnetic resonance angiography is associated with advanced coronary artery calcification. 
  • Importance of echocardiography in patients with severe nonischemic heart failure: the second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) echocardiographic study. 
  • In vivo imaging of rat coronary arteries using bi-plane digital subtraction angiography. 
  • Incidence of caffeine in serum of patients undergoing dipyridamole myocardial perfusion stress test by an intensive versus routine caffeine history screening. 
  • Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation. 
  • Incremental prognostic value of RNA ejection fraction measurements during pharmacologic stress testing: a comparison with clinical and perfusion variables. 
  • Influence of lemakalim on the pulmonary vascular bed of the cat. 
  • Inhaled Iloprost Versus Epoprostenol in Heart Transplant Recipients. 
  • Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials. 
  • Inhaled Pulmonary Vasodilator Therapy in Adult Lung Transplant: A Randomized Clinical Trial. 
  • Inhaled epoprostenol during one-lung ventilation. 
  • Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. 
  • Inhaled nitric oxide therapy increases blood nitrite, nitrate, and s-nitrosohemoglobin concentrations in infants with pulmonary hypertension. 
  • Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial. 
  • Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure. 
  • Intensity and focus of heart failure disease management after hospital discharge. 
  • Interactions between propofol and lipid mediator receptors: inhibition of lysophosphatidate signaling. 
  • Intraoperative fluid management during orthotopic liver transplantation. 
  • Intrapulmonary Milrinone for Cardiac Surgery Provides Insight Into Precision Delivery of Aerosolized Vasodilators. 
  • Intravenous nisoldipine in severe congestive heart failure. 
  • Investigating the relationship between rosacea and use of vasodilatory medications in a hospital-wide population. 
  • Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. 
  • Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease. 
  • Isolated subglottic hemangiomas: A potential diagnostic challenge in the absence of a cutaneous clue. 
  • Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. 
  • Licorice-associated reversible cerebral vasoconstriction with PRES. 
  • Local 42 degrees C hyperthermia improves vascular conductance of the R3230Ac rat mammary adenocarcinoma during sodium nitroprusside infusion. 
  • Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure. 
  • Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. 
  • MRI quantitative myocardial perfusion with compartmental analysis: a rest and stress study. 
  • Management of acute decompensated heart failure. 
  • Management of systemic and pulmonary hypertension. 
  • Means for load variation during echocardiographic assessment of the Frank-Starling relationship. 
  • Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). 
  • Measurement of vascular input impedance in infrainguinal vein grafts. 
  • Medical advances in the treatment of congestive heart failure. 
  • Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. 
  • Molecular profile and partial functional analysis of novel endothelial cell-derived growth factors that regulate hematopoiesis. 
  • Multicenter Validation of the Vasoactive-Ventilation-Renal Score as a Predictor of Prolonged Mechanical Ventilation After Neonatal Cardiac Surgery. 
  • My hair is thinning on the top of my head. What treatments are available for hair loss in women? 
  • Nebulized prostacyclin for pulmonary hypertension: a step in the right direction. 
  • Neurohumoral mechanisms in heart failure: role in pathogenesis, therapy, and drug tolerance. 
  • Newer pharmacologic alternatives for erectile dysfunction. 
  • Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. 
  • Nonlocalized lower gastrointestinal bleeding: provocative bleeding studies with intraarterial tPA, heparin, and tolazoline. 
  • Overview of current noninodilator therapies for acute heart failure syndromes. 
  • PINOT NOIR: pulmonic insufficiency improvement with nitric oxide inhalational response. 
  • Pathophysiology and related studies of the no reflow phenomenon in skeletal muscle. 
  • Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients. 
  • Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. 
  • Pharmacologic Targeting of Red Blood Cells to Improve Tissue Oxygenation. 
  • Pharmacologic activation of the human coronary microcirculation in vitro: endothelium-dependent dilation and differential responses to acetylcholine. 
  • Pharmacologic management of perioperative pulmonary hypertension. 
  • Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. 
  • Pharmacological regulation of outflow resistance distal to Schlemm's canal. 
  • Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents. 
  • Posterior optic nerve ischemic neuropathy in the setting of phenoxybenzamine therapy after uneventful spinal fusion. 
  • Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol. 
  • Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: a comparison between 99mTc-tetrofosmin and 99mTc-sestamibi. 
  • Predictors of hemodynamic instability during surgery for pheochromocytoma. 
  • Pregnancy and estradiol decrease GTPase activity in the guinea pig uterine artery. 
  • Preservation of renal blood flow during hypotension induced with fenoldopam in dogs. 
  • Prevention of atrial fibrillation following cardiac surgery. 
  • Prevention of chronic cerebral vasospasm in dogs with milrinone. 
  • Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis. 
  • Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction. 
  • Prognostic Implications of Blunted Feature-Tracking Global Longitudinal Strain During Vasodilator Cardiovascular Magnetic Resonance Stress Imaging. 
  • Prognostic Value of Vasodilator Stress Cardiac Magnetic Resonance Imaging: A Multicenter Study With 48 000 Patient-Years of Follow-up. 
  • Prophylaxis against postoperative atrial fibrillation: current progress and future directions. 
  • Pulmonary Hypertension in Pregnancy: A Report of 49 Cases at Four Tertiary North American Sites. 
  • Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. 
  • Pulmonary vasodilator responses to RP 52891 are mediated by activation of a glibenclamide-sensitive K+ATP channel. 
  • Quantifying Intra-Arterial Verapamil Response as a Diagnostic Tool for Reversible Cerebral Vasoconstriction Syndrome. 
  • Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. 
  • Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II. 
  • Relaxin, a pleiotropic vasodilator for the treatment of heart failure. 
  • Renal and circulatory mechanisms in congestive heart failure. 
  • Respiratory effects of pressor and depressor agents in conscious rats. 
  • Responses of normal and sickle cell hemoglobin to S-nitroscysteine: implications for therapeutic applications of NO in treatment of sickle cell disease. 
  • Responses to propofol in the pulmonary vascular bed of the rat. 
  • Reversal of right-ventricular dysfunction in pulmonary arterial hypertension following sildenafil therapy. 
  • Right ventricular failure--insights provided by a new model of chronic pulmonary hypertension. 
  • Role of K+ATP channels and EDRF in reactive hyperemia in the hindquarters vascular bed of cats. 
  • S-nitrosoglutathione inhibits alpha1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery. 
  • S-nitrosohemoglobin is distinguished from other nitrosovasodilators by unique oxygen-dependent responses that support an allosteric mechanism of action. 
  • SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials. 
  • Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients. 
  • Safety of nifedipine in angina pectoris: a meta-analysis. 
  • Safety of nifedipine in patients with hypertension: a meta-analysis. 
  • Salivary levels of angiopoietin-2 in infants with infantile haemangiomas treated with and without systemic propranolol. 
  • Significance of indeterminate and abnormal stress electrocardiography despite normal imaging in patients with suspected coronary artery disease - An analysis of the PROMISE trial. 
  • Sildenafil Exposure in the Neonatal Intensive Care Unit. 
  • Sildenafil and retinopathy of prematurity risk in very low birth weight infants. 
  • Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy. 
  • Sildenafil improves walk distance in idiopathic pulmonary fibrosis. 
  • Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. 
  • Sildenafil: Possible Prophylaxis against Swimming-induced Pulmonary Edema. 
  • Single photon emission computed tomography myocardial imaging: clinical applications and future directions. 
  • Stimulation of long-chain fatty acid uptake by dipyridamole in isolated myocytes. 
  • Stress echocardiography, contrast echocardiography, and tissue characterization: applications for the future. 
  • Sublingual aerosol nitroglycerin for uterine relaxation in attempted external version. 
  • Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries. 
  • Support of the perioperative failing heart with preexisting ventricular dysfunction: currently available options. 
  • Surrogate end points in heart failure trials. 
  • Swimming-Induced Pulmonary Edema: Pathophysiology and Risk Reduction With Sildenafil. 
  • Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? 
  • TRPV4-dependent dilation of peripheral resistance arteries influences arterial pressure. 
  • Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4). 
  • Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4). 
  • Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4). 
  • Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). 
  • The Influence of Topical Vasodilator-Induced Pharmacologic Delay on Cutaneous Flap Viability and Vascular Remodeling. 
  • The desaturation response time of finger pulse oximeters during mild hypothermia. 
  • The effect of treatment on the presence of abnormal heart sounds in emergency department patients with heart failure. 
  • The effects of acute afterload change on systolic ventricular function in conscious dogs with normal vs. failing hearts. 
  • The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. 
  • The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery. 
  • The in vitro reversal of histamine-induced vasodilation in the human internal mammary artery. 
  • The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic. 
  • The relaxant effect of diazoxide on isolated gravid and nongravid human myometrium. 
  • The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use. 
  • The vasodilator effects of clevidipine on human internal mammary artery. 
  • The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery. 
  • Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review. 
  • Treatment strategies for microvascular dysfunction following acute myocardial infarction. 
  • Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice. 
  • Unexpected Cardiac MRI Findings in Patients Presenting to the Emergency Department for Possible Acute Coronary Syndrome. 
  • Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. 
  • Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. 
  • Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failure. 
  • Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial). 
  • Utilization of inhaled nitric oxide after surgical repair of truncus arteriosus: A multicenter analysis. 
  • Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States: The Severe ARDS: Generating Evidence Study. 
  • Variation in perioperative vasoactive therapy in cardiovascular surgical care: data from the Society of Thoracic Surgeons. 
  • Vascular Response to Sildenafil Citrate in Aging and Age-Related Macular Degeneration. 
  • Vascular and renal prostaglandins as counter-regulatory systems in heart failure. 
  • Vasodilator Stress Magnetic Resonance Imaging in Patients With Prior Myocardial Infarction. 
  • Vasodilator action of prostaglandin E1 on microcirculation of rat cremaster muscle. 
  • Vasodilator administration in the presence of beta-adrenergic blockade. 
  • Vasodilator monotherapy in the treatment of hypertension: comparative efficacy and safety of pinacidil, a potassium channel opener, and prazosin. 
  • Vasodilators in aortic regurgitation. 
  • Vasodilators in the management of congestive heart failure. 
  • Vasodilators in the treatment of acute heart failure: what we know, what we don't. 
  • Vessel dilator, long acting natriuretic peptide, and kaliuretic peptide increase circulating prostaglandin E2. 
  • When 'blue babies' grow up: What you need to know about tetralogy of Fallot. 
  • Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study. 
  • [Nphe1]nociceptin(1-13)-NH2 antagonizes nociceptin-induced hypotension, bradycardia, and hindquarters vasodilation in the anesthetized rat. 
  • [Prostaglandin E1 for prevention of contrast medium-induced kidney dysfunction]. 
• 

  Keywords of People

  • Bennett, Vann, George Barth Geller Distinguished Professor of Molecular Biology, Duke Cancer Institute
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology